Persistent Asset Partners »

4d Molecular Therapeutics In shares owned by Persistent Asset Partners

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Persistent Asset Partners from 13F filings

Historical chart of Persistent Asset Partners investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Persistent Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Persistent Asset Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.9M 146k 13.30

More positions owned by Persistent Asset Partners

Intel Corporation Call Option (INTC)
Kla Corp Com New Call Option (KLAC)
Nebius Group Shs Class A Call Option (NBIS)
Kodiak Sciences Call Option (KOD)
Novo-nordisk A S Adr Put Option (NVO)
Corning Incorporated Call Option (GLW)
Vaxcyte Call Option (PCVX)
Micron Technology Call Option (MU)
Monte Rosa Therapeutics Call Option (GLUE)
Robinhood Mkts Com Cl A (HOOD)
Arcus Biosciences Incorporated Call Option (RCUS)
Stmicroelectronics N V Ny Registry (STM)
Uniqure Nv SHS Call Option (QURE)
Amphenol Corp Cl A (APH)
Marvell Technology Call Option (MRVL)

View all positions for Persistent Asset Partners

Top funds holding 4d Molecular Therapeutics In

Jupiter Topco
Henderson Group
RA Capital Management
BlackRock
Goldman Sachs Group
Novo A/S
BVF
State Street Corporation
Adage Capital Partners GP
Trails Edge Capital Partners
Vanguard Capital Management
Armistice Capital
Geode Capital Management
Bank of America Corporation
Evergreen Quality Fund GP

View all funds holding 4d Molecular Therapeutics In